These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4051803)
1. [Structural and biochemical characteristics of the effectiveness of intraoperative protection of the myocardium]. Mogilevskiĭ GM; Sharov VG; Saks VA; Semenovskiĭ ML Arkh Patol; 1985; 47(6):24-9. PubMed ID: 4051803 [TBL] [Abstract][Full Text] [Related]
2. Protection of ischemic myocardium by exogenous phosphocreatine. II. Clinical, ultrastructural, and biochemical evaluations. Semenovsky ML; Shumakov VI; Sharov VG; Mogilevsky GM; Asmolovsky AV; Makhotina LA; Saks VA J Thorac Cardiovasc Surg; 1987 Nov; 94(5):762-9. PubMed ID: 3312824 [TBL] [Abstract][Full Text] [Related]
3. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia. Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645 [TBL] [Abstract][Full Text] [Related]
4. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. Experimental and clinical study. Follette DM; Mulder DG; Maloney JV; Buckberg GD J Thorac Cardiovasc Surg; 1978 Nov; 76(5):604-19. PubMed ID: 703365 [No Abstract] [Full Text] [Related]
5. [Evaluation of the efficacy of human heart protection during cardioplegia]. Krymskiĭ LD; Artiukhina TV; Blagoveshchenskaia RP Arkh Patol; 1983; 45(1):17-25. PubMed ID: 6847399 [TBL] [Abstract][Full Text] [Related]
6. [Intraoperative myocardial protection with extracellular cardioplegic solutions in patients with cardiac valve diseases]. Zhidkov IL; Ivanov VA; Kozhevnikov VA; Charnaia MA; Mukhamedzianova AR; Trekova NA Anesteziol Reanimatol; 2007; (2):38-42. PubMed ID: 17563998 [TBL] [Abstract][Full Text] [Related]
8. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog. Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386 [TBL] [Abstract][Full Text] [Related]
9. [Morphologic and biochemical criteria of the efficacy of clinical use of phosphocreatine (neoton) for intraoperative protection of the myocardium]. Chazov EI; Semenovskiĭ ML; Smirnov VN; Shumakov VI; Saks VA Fiziol Zh (1978); 1986; 32(1):3-13. PubMed ID: 3956779 [No Abstract] [Full Text] [Related]
10. Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study. Flameng W; Van der Vusse GJ; De Meyere R; Borgers M; Sergeant P; Vander Meersch E; Geboers J; Suy R J Thorac Cardiovasc Surg; 1984 Aug; 88(2):164-73. PubMed ID: 6379305 [TBL] [Abstract][Full Text] [Related]
11. Aortic valve replacement: better myocardial protection by cold or warm retrograde blood cardioplegia? Boening A; Sanuri M; Buchwald D; Laczkovics AM J Heart Valve Dis; 1996 May; 5(3):273-80. PubMed ID: 8793675 [TBL] [Abstract][Full Text] [Related]
12. Protection of the chronic hypoxic immature rat heart during global ischemia. Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715 [TBL] [Abstract][Full Text] [Related]
13. [Method and results of a new kind of artificially induced cardioplegia in experiments with animals and under clinical conditions (author's transl)]. Nordbeck H; Bretschneider HJ; Fuchs C; Knoll D; Kohl FV; Sakai K; Spieckermann PG; Stapenhorst K Thoraxchir Vask Chir; 1974 Dec; 22(6):582-7. PubMed ID: 4616427 [No Abstract] [Full Text] [Related]
14. Effectiveness of continuous warm blood cardioplegia in cardiac valve re-replacement. Nagaoka H; Hirooka K; Ohnuki M; Fujiwara N J Heart Valve Dis; 1999 Mar; 8(2):124-30. PubMed ID: 10224569 [TBL] [Abstract][Full Text] [Related]